Oncocyte Signs Leading Transplant Centers in US and Germany
October 02, 2024 18:41 ET
|
OncoCyte Corporation
GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volumeCompany clears first stage gate in clinical product development process and has...
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
August 20, 2024 09:00 ET
|
PRISM MarketView
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
August 12, 2024 16:10 ET
|
OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
August 08, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
The Eclipse Foundation Announces Agenda and Keynote Speakers for Open Community Experience (OCX 2024), Europe’s Premier Event for Open Source Innovation
August 06, 2024 07:00 ET
|
Eclipse Foundation Canada
BRUSSELS, Belgium, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source foundations, has unveiled the agenda and speakers for the inaugural Open...
Oncocyte Announces August Investor Conferences Participation
August 05, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte Announces August Investor Conferences Participation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
August 01, 2024 16:05 ET
|
OncoCyte Corporation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
July 11, 2024 08:00 ET
|
Med Tech Gurus
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move
June 24, 2024 12:41 ET
|
PRISM MarketView
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
June 03, 2024 14:13 ET
|
PRISM MarketView
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study